Titan Medical Inc. announced that the Company has entered into a licensing agreement with Auris Health, Inc. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan?s IP.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | 0.00% | -8.33% | -31.25% |
05-13 | Titan Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-22 | Titan Medical Provides Update on Merger with Conavi | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.25% | 4.61M | |
+12.61% | 229B | |
+13.63% | 195B | |
+18.25% | 142B | |
+29.01% | 109B | |
+3.23% | 64.85B | |
+18.64% | 54.33B | |
+7.04% | 52.09B | |
+10.85% | 45.15B | |
+4.77% | 37.39B |
- Stock Market
- Equities
- TMD Stock
- News Titan Medical Inc.
- Titan Medical Signs License Agreement with Auris Health, Inc